Search

everythinglearnresearchcommunity

for

Search:↓

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Regenerative treatments for vitiligo show promise but need more research for long-term safety and effectiveness.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Mycosis fungoides can have unusual symptoms and may be misdiagnosed, but specific cell markers might suggest a lower risk of worsening.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

Lichen Planopilaris causes irreversible hair loss due to immune attacks on hair stem cells, but modulating PPAR-γ might help treat it.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Vitamin B3 may help prevent hair loss and promote hair growth by protecting scalp cells from stress and reducing hair growth-blocking proteins.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Understanding hair follicles through various models can help develop new treatments for hair disorders.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Hidradenitis suppurativa tunnels worsen the disease and often need surgery because current treatments are not very effective.

Targeting CXCL12 may help treat hair loss caused by androgens.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.